logo-loader
Energy
Faroe Petroleum plc

Cantor says remaining Faroe Petroleum shareholders should cash out

DNO now has the backing of more than 72% of Faroe's shares

oil and gas operations
“Faroe’s board finally threw in the towel yesterday"

Remaining Faroe Petroleum plc (LON:FPM) shareholders should hand over their shares to hostile acquirer DNO, that’s the view of analysts at Cantor Fitzgerald.

DNO yesterday revealed it had taken a controlling stake in Faroe, as acceptances of its improved 160p per share offer passed 52.44%, then this morning the latest stock market statement confirmed that it now had 72.8%.

READ: Faroe Petroleum taken out by DNO, could more North Sea oilers follow?

“Faroe’s board finally threw in the towel yesterday … verbal sparring had continued between the pair over the festive period and into the New Year, with buying taking DNO’s existing stake to over 30% and making its original 152p offer mandatory before it opted to increase this and set a final closing date,” Cantor analyst Ashley Kelty said in a note.

He added: “While we agree with Faroe’s board that the offer remains low - our updated valuation implies over 20% upside – weak recent newsflow and market conditions have, perhaps unsurprisingly, swayed shareholders.

“Given the potential uncertainty over the company’s future under DNO’s control, we believe that shareholders should now tender their shares, and are bringing our target price in line with the offer, at 160p (from 195p).”

Faroe executive chairman Bijan Mossavar-Rahmani, in today’s statement, said: "The majority of Faroe's shareholders have now spoken and the Faroe board has disclosed that its members, too, will accept DNO's offer in respect of their own holdings.

“We also note, and appreciate, the intent of Faroe's board to work with DNO to ensure an orderly transition of control of the company. That is indeed in the interest of all stakeholders.”

Quick facts: Faroe Petroleum plc

Price: £0.00

Market: AIM
Market Cap: £0.00
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

10 hours, 10 minutes ago

2 min read